The biotechnology sector’s outperformance amid the pandemic has led some analysts to refer to this time as the “golden period of biotechnology”. When it comes to the best biotech stock picks, the author of today’s article identifies three parameters to consider: “hedge fund and institutional investor sentiment towards the stock, market performance, quarterly results and competitive advantage.” With this in mind, he highlights three biotech stocks that appear poised for massive growth going forward – and, not surprisingly, all three are participants in the race for a COVID-19 vaccine. For more, CLICK HERE.